Clinical Trial Update: COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

View source ↗

Summary

Status update for the COMBINE-P trial evaluating combined PSMA-PET/CT and MRI staging in intermediate- and high-risk prostate cancer. The sponsor Heinrich-Heine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Intermediate-risk Prostate Cancer, High-risk Prostate Cancer | Status: ACTIVE_NOT_RECRUITING